Table 4B.
Subgroup meta-analysis for studies reporting development of reactive arthritis following NTS infection by sequelae diagnosis, follow-up period, study size and healthcare facility visited.
| Variable | I2 | Number of studies |
|---|---|---|
| Sequelae diagnosis | ||
| Physician/medical records | 97.7% | 9 |
| Self-reported disease status | 96.8% | 9 |
| Self-reported disease status based on a validated scale | – | 1 |
| Specialista | 41.2% | 6 |
| Combination | – | 1 |
| Not reported | – | 1 |
| Follow-up period | ||
| < 3 months | 97.3% | 10 |
| 3 months | 81.3% | 5 |
| > 3 months < 1 year | 93.5% | 4 |
| 1 year | 97.8% | 2 |
| > 1 year | 95.3% | 2 |
| Not reported | 97.7% | 4 |
| Study size | ||
| Extra small (n < 100) | 58.8% | 7 |
| Small (101–500) | 95.6% | 16 |
| Medium (501–1000) | 96.1% | 1 |
| Large (1001–10,000) | – | 1 |
| Extra-large (> 10.000) | 99.80% | 1 |
| Healthcare facility visited | ||
| GP/physiciana | 2.0% | 3 |
| GP/hospitalised | – | 1 |
| A&E/hospitalised | 99.9% | 2 |
| Hospitalised | 91.7% | 5 |
| Not reported | 98.8% | 20 |
a
Heterogeneity significantly reduced (I2 < 50%).